Insulin glargine improves glycaemic control after coronary surgery in patients with diabetes or pre-diabetes

Scandinavian Cardiovascular Journal

Volumn 42, Issue 1, 2008, Pages 71-76

  Hagelberg, A ^a   Ivert, T ^a   Efendic S ^a   Ohrvik J ^a   Anderson, R E ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CABG; Diabetes; Insulin glargine; OGTT

Indexed keywords

INSULIN GLARGINE; NEUTRAL INSULIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY SURGERY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; BLOOD GLUCOSE; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PILOT PROJECTS; PREDIABETIC STATE; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 41549097714     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430701721756     Document Type: Article

References (13)

1. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27:553-91.
2. Anderson RE, Brismar K, Ivert T. Only a minority of patients referred for elective coronary artery bypass surgery have risk factors diagnosed and treated according to established guidelines. J Diab Vasc Dis Research. 2007 (in press).
3. Anderson RE, Klerdal K, Ivert T, Hammar N, Barr G, Öwall A. Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery? Eur Heart J. 2005;26:1513-8.
4. Doenst T, Wijeysundera D, Karkouti K, Zechner C, Maganti M, Rao V, et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. Thorac Cardiovasc Surg. 2005; 130:1144.
5. McAlister FA, Man J, Bistritz L, Amad H, Tandon Pl. Diabetes and coronary artery bypass surgery: An examination of perioperative glycemic control and outcomes. Diabetes Care. 2003;26:1518-24.
6. Furnary AP, Wu Y. Clinical effects of hyperglycemia in the cardiac surgery population: The portland diabetic project. Endocr Pract. 2006;S3:22-6.
7. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-67.
8. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78:1471-8.
9. Nishikawa T, Araki E. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal. 2007;9:343-53.
10. Rask-Madsen C, King GL. Mechanisms of disease: Endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab. 2007;3:46-56.
11. Di Filippo C, Cuzzocrea S, Rossi F, Marfella R, D'Amico M. Oxidative stress as the leading cause of acute myocardial infarction in diabetics. Cardiovasc Drug Rev. 2006;24:77-87.
12. Scognamiglio R, Negut C, De Kreutzenberg SV, Tiengo A, Avogaro A. Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients. Circulation. 2005; 112:179-84.
13. Vriesendorp TM, DeVries JH, van Santen S, Moeniralam HS, de Jonge E, Roos YB, et al. Evaluation of short-term consequences of hypoglycaemia in an intensive care unit. Crit Care Med. 2006;34:2714-8.